A METHOD FOR OBTAINING A VACCINE AGAINST THE DIFFERENT PATHOGENIC SEROTYPES OF GROUP B NEISSERIA MENINGITIDIS

A method is provided for obtaining a vaccine against the different pathogenic serotypes of group B Neisseria meningitidis characterized by starting from live microorganisms of any one of the known pathogenic serotypes of the B group without inactivation, from which the extractation of the vesicles o...

Full description

Saved in:
Bibliographic Details
Main Authors LUIS GUILLERMO GARCIA IMIA, VICTORIANO GUSTAVO SIERRA GONZALEZ, FRANKLIN SOTOLONGO PADRON, MARIA MERCEDES CUTIERREZ VAZQUEZ, GISELA DE LA CARIDAD PUENTES RIZO, MARIA DEL CARMEN SAMPEDRO HERRERA, ELOISA XOCHITL LE RIVEREND MORALES, MANUEL ALFREDO GALGUERA DOMINGUEZ, CONCEPCION CAMPA HUERGO, GONZALO BISSET JORRIN
Format Patent
LanguageEnglish
Published 24.11.1990
Edition5
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A method is provided for obtaining a vaccine against the different pathogenic serotypes of group B Neisseria meningitidis characterized by starting from live microorganisms of any one of the known pathogenic serotypes of the B group without inactivation, from which the extractation of the vesicles of the outer membrane and the protein antigenic complex of 65 - 95 KD molecular weight is carried out using detergent, enzyme and ultrasound combined in the treatment. The resulting product, after treatment to eliminate the nucleic acids, is purified by a dissociating treatment with detergent, ultrasonic bath and column chromatography. The multi-antigenic material so obtained is purified to obtain the protein antigenic complex of 65 - 95 KD molecular weight for HPLC chromatography (TSK 3000 SWG column) or affinity chromatography with monoclonal antibodies, or hydrophobicity chromatography, or ionic exchange chromatography or a combination of any one of them. The protein antigenic complex is then added to the fraction that contains the vesicles by ultrasound treatment so that it will be anchored on then, in a proportion of 15 por cent +/- 3. The capsulr polysaccharide is also added, in a proportion of 1.1 - 1.4 with respect to the protein and the adjuvant in a relation ranging from 2 - 100 mcg/protein mcg. The different components ot the mixture may be sterilized by cobalt 60 inonizing radiations with doses from 5 - 25 Kgy and a temperature between 1 - 4 grade C before preparing the mixture or the resulting mixture may be sterilized by this procedure.
Bibliography:Application Number: IN626MA1988